Bavencio Review Timeline And Reviewers
Overview of development timeline and review team for EMD Serono’s Bavencio (avelumab) for metastatic Merkel cell carcinoma.
You may also be interested in...
Breakthrough-designated oncologics used historical comparator data to determine efficacy threshold for pivotal Phase II studies supporting accelerated approval; Blincyto’s subsequent full approval offers validation with conventional controlled study.
Keeping Track: US FDA Clears On Target’s Cytalux, VBI’s PreHevbrio; Keytruda Grows In Adjuvant Melanoma
The latest FDA approval news and highlights from the Pink Sheet’s US FDA Performance Tracker.
The latest news about applications under FDA review, from the Pink Sheet’s US FDA Performance Tracker